Myofiber size correlates with MTM1 mutation type and outcome in X-linked myotubular myopathy

Area of Science:

• Neurology
• Genetics
• Pathology

Background:

• X-linked myotubular myopathy (XLMTM) is a severe congenital muscle disorder.
• The myotubularin (MTM1) gene is the primary cause of XLMTM.
• Understanding genotype-phenotype correlations is crucial for XLMTM management.

Purpose of the Study:

• To correlate pathological findings with MTM1 mutation types in XLMTM.
• To investigate the relationship between myofiber size and clinical outcomes in XLMTM patients.

Main Methods:

• Analysis of clinical data and muscle biopsies from 15 XLMTM patients.
• Morphometric studies of myofiber diameter and central nuclei proportion.
• Correlation of pathological findings with MTM1 mutation types (missense vs. truncation/deletion).

Main Results:

• Myofiber diameter in infancy was significantly larger in survivors compared to non-survivors.
• Patients with MTM1 missense mutations exhibited larger myofiber diameters than those with truncation/deletion mutations.
• The proportion of myofibers with central nuclei did not correlate with clinical outcome.

Conclusions:

• Myofiber size is a key pathological feature in XLMTM that correlates with MTM1 mutation type.
• Larger myofiber diameter in infancy is associated with a better clinical outcome in XLMTM.
• Failure to attain/maintain myofiber size contributes to XLMTM muscle pathology.